Position in RXRX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$560,612
-$135,861 QoQ
Shares Held
182,610
+7.2% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Derivatives in RXRX
reported options exposure · as of Dec 31, 2025CallValue
$122,700
CallShares
30,000
PutValue
$122,700
PutShares
30,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,427,117,007 across 402 Biotechnology names. RXRX ranks #111 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in RXRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $560,612 | 182,610 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $696,473 | 170,287 | Shares | Defined | 2026-02-13 | |
| 2025-12-31 | $122,700 | 30,000 | Put | Defined | 2026-02-13 | |
| 2025-12-31 | $122,700 | 30,000 | Call | Defined | 2026-02-13 | |
| 2025-09-30 | $324,036 | 66,401 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $1,086,618 | 214,747 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $3,488,483 | 659,449 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,386,677 | 500,988 | Shares | Defined | 2025-02-12 | |
| 2024-12-31 | $149,396 | 22,100 | Call | Defined | 2025-02-12 | |
| 2024-12-31 | $149,396 | 22,100 | Put | Defined | 2025-02-12 | |
| 2024-09-30 | $1,257,054 | 190,752 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $777,074 | 103,610 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $7,987,833 | 801,187 | Shares | Defined | 2024-05-10 | |
| 2024-03-31 | $625,119 | 62,700 | Put | Defined | 2024-05-10 | |
| 2023-12-31 | $3,991,850 | 404,853 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,599,416 | 470,512 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $1,324,713 | 177,338 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $4,590,460 | 688,225 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,795,096 | 232,827 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $1,718,997 | 161,560 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $100,121 | 12,300 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $106,676 | 14,899 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $4,185,835 | 244,357 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $1,042,214 | 45,294 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $36,719 | 1,006 | Shares | Defined | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||